All stock lists
ExxonMobil Holdings Corporation (New York Stock Exchange:XOM)
US · Delayed Price · Currency is USD
Also listed: 7DZ.DE, XOM.MX, XOM.SWEnergy · Oil & Gas Integrated
$166.71+$2.24 (+1.36%)
Market cap
$680B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 13, 1978
Website
Insider Score
––Not scored
XOM Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
XOM analyst forecast
XOM analyst consensus
Moderate Buy9 ratings
Buy 5 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
XOM 12-month price target
$165.60-0.7% downsideaverage of 10 firms
$199.00High
$123.00Low
Best analysts covering XOM
- Morgan Stanley100%success rate · +17.8% avg return · 16 calls
- JP Morgan100%success rate · +20.7% avg return · 5 calls
- Evercore ISI Group100%success rate · +8.6% avg return · 1 call
- Jefferies100%success rate · +20.2% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
XOM analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Freedom Broker | Hold | — | — | Reiterated | 2026-11-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-11-04 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-11-04 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-11-02 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-11-02 |
| — | UBS | Buy | — | — | Reiterated | 2026-11-02 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-11-02 |
| Goldman Sachs | — | $178.00 | -0.2% | — | 2026-10-20 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-19 |
| UBS | — | $199.00 | +12.2% | — | 2026-10-19 | |
| Goldman Sachs | — | $169.00 | -4.7% | — | 2026-10-16 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-10-15 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2026-10-01 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-09-28 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-09-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-19 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-17 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-07 |
| — | Freedom Broker | Hold | — | — | Upgraded | 2026-08-04 |
| Wells Fargo | — | $182.00 | +17.1% | — | 2026-08-03 | |
| — | B of A Securities | Neutral | — | — | Downgraded | 2026-07-28 |
| Piper Sandler | — | $158.00 | +2.3% | — | 2026-07-23 | |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-07-09 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-07-02 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-06-29 |
| — | B of A Securities | Buy | — | — | Upgraded | 2026-06-16 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-05-27 |
| Barclays | Overweight | $182.00 | +17.5% | Reiterated | 2026-05-26 | |
| Bernstein | Outperform | $182.00 | +26.0% | Reiterated | 2026-05-11 | |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-05-05 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-04 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2026-04-22 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2026-04-21 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-04-17 |
| BNP Paribas | Neutral | $165.00 | +8.7% | Upgraded | 2026-04-17 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-10 |
| Wells Fargo | Overweight | $185.00 | +19.3% | Reiterated | 2026-04-09 | |
| Piper Sandler | Overweight | $182.00 | +17.4% | Reiterated | 2026-04-09 | |
| — | Jefferies | Buy | — | — | Reiterated | 2026-04-09 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-09 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-04-09 |
| Wolfe Research | Outperform | $153.00 | -2.1% | Reiterated | 2026-04-08 | |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-04-02 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-27 |
| — | HSBC | Hold | — | — | Reiterated | 2026-03-20 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-03-17 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-16 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-03-12 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-03-02 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-03-02 |
| Wells Fargo | Overweight | $183.00 | +21.3% | Reiterated | 2026-02-24 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-03 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-02-03 |
| Loop Capital Markets | — | $123.00 | -14.5% | — | 2026-02-03 | |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-02 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-02-02 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-01-28 |
XOM earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-30 | $1.70 | $1.71 | $80.63B | $82.31B |
| 2026-05-01 | $0.98 | $1.16 | $81.13B | $85.14B |
| 2026-07-31 | $3.56 | $3.52 | $109.94B | $116.02B |
| 2026-10-30 | $4.12 | $4.23 | $104.89B | $113.16B |
| 2027-01-29Upcoming | $4.09 | — | $117.83B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.